Citation Impact
Citing Papers
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Computational design of closely related proteins that adopt two well-defined but structurally divergent folds
2020 StandoutNobel
Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection
2007
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
2014 StandoutNobel
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
2010
Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants
2011
Stalking influenza by vaccination with pre-fusion headless HA mini-stem
2016
Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins
2022 StandoutNobel
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
2020
Broadly neutralizing antibodies against influenza virus and prospects for universal therapies
2012
M2e-based universal influenza A vaccine
2009
Influenza virus hemagglutinin stalk-based antibodies and vaccines
2013
Immune responses to influenza virus infection
2011
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
2006 StandoutNature
Use of hepadnavirus core proteins as vaccine platforms
2009
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response
2004
The costimulatory genes Cd80 and Cd86 are linked on mouse chromosome 16 and human chromosome 3
1997
Enhanced Influenza Virus-Like Particle Vaccines Containing the Extracellular Domain of Matrix Protein 2 and a Toll-Like Receptor Ligand
2012
Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells
2009
Cloning and chromosomal mapping of the human p53-related KET gene to Chromosome 3q27 and its murine homolog Ket to mouse Chromosome 16
1998
Structure of Dengue Virus
2002 Standout
Computational Design of High-Affinity Epitope Scaffolds by Backbone Grafting of a Linear Epitope
2011 StandoutNobel
Structural insights into the design of novel anti-influenza therapies
2018
Computational Design of Novel Protein Binders and Experimental Affinity Maturation
2013 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 StandoutNatureNobel
Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
2013
A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation
1995
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
2006
Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site
2008
A mouse model for Down syndrome exhibits learning and behaviour deficits
1995 Standout
Novel universal influenza virus vaccine approaches
2016
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site
2017 StandoutNobel
Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines
2013
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
2011
Survey of the year 2003 commercial optical biosensor literature
2004
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
1999 StandoutNature
Down's syndrome
2003 Standout
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment
2005
Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide
2010
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Evolutionary Breakpoints on Human Chromosome 21
2001
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Survey of the year 2005 commercial optical biosensor literature
2006
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
2015
Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine
2011
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion
2003
Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice
2018
Adaptive immunity to SARS-CoV-2 and COVID-19
2021
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
2005
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope
2004
Acid potentiation of the capsaicin receptor determined by a key extracellular site
2000 StandoutNobel
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
2006
Advances in the development of influenza virus vaccines
2015
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
2000 StandoutNobel
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes
2007
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
2012 Science
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
2005
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody
2007
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
2005 Science
Design and Characterization of Stabilized Derivatives of Human CD4D12 and CD4D1
2011 StandoutNobel
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
2011 Science
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
2009
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Structural Basis for the Development of Avian Virus Capsids That Display Influenza Virus Proteins and Induce Protective Immunity
2014
Virus and Cell Fusion Mechanisms
2014
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Neuropathology of Degenerative Cell Death inCaenorhabditis elegans
1997 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5
2004
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications
2009
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
2013
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Role of HIV membrane in neutralization by two broadly neutralizing antibodies
2009
Works of Michael Citron being referenced
Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro
2002
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
2004
Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
2008
Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype
2015
High-Resolution Recombinational Map of Mouse Chromosome 16
1997
High-Resolution Mapping of D16Led-1, Gart, Gas-4, Cbr, Pcp-4, and Erg on Distal Mouse Chromosome 16
1993
The positions of 12 simple sequence repeat markers relative to reference loci on mouse Chromosome 16
1993
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates
2020
A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates
2018
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
2009
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection
2014
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
2010
Characterization of gp120 and Its Single-Chain Derivatives, gp120-CD4D12and gp120-M9: Implications for Targeting the CD4iEpitope in Human Immunodeficiency Virus Vaccine Design
2005
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
2010
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies
2006
Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge
2012
HIV-1 Vaccine Development: Constrained Peptide Immunogens Show Improved Binding to the Anti-HIV-1 gp41 MAb
2003